{
    "id": 26503,
    "fullName": "EPHB4 positive",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "EPHB4 positive indicates the presence of the EPHB4 gene, mRNA, and/or protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 2050,
        "geneSymbol": "EPHB4",
        "terms": [
            "EPHB4",
            "CMAVM2",
            "HFASD",
            "HTK",
            "LMPHM7",
            "MYK1",
            "TYRO11"
        ]
    },
    "variant": "positive",
    "createDate": "05/03/2017",
    "updateDate": "05/03/2017",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 10747,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, sEphB4-HSA inhibited growth of Ephb4-positive non-small cell lung carcinoma cell lines in culture and reduced tumor volume in cell line xenograft models (PMID: 23844053).",
            "molecularProfile": {
                "id": 27742,
                "profileName": "EPHB4 positive"
            },
            "therapy": {
                "id": 3013,
                "therapyName": "sEphB4-HSA",
                "synonyms": null
            },
            "indication": {
                "id": 3908,
                "name": "lung non-small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4341,
                    "pubMedId": 23844053,
                    "title": "The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic target.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23844053"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 10749,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, combination of sEphB4-HSA and Taxol (paclitaxel) resulted in complete remission in cell line xenograft models of Ephb4-positive non-small cell lung carcinoma (PMID: 23844053).",
            "molecularProfile": {
                "id": 27742,
                "profileName": "EPHB4 positive"
            },
            "therapy": {
                "id": 5605,
                "therapyName": "Paclitaxel + sEphB4-HSA",
                "synonyms": null
            },
            "indication": {
                "id": 3908,
                "name": "lung non-small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4341,
                    "pubMedId": 23844053,
                    "title": "The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic target.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23844053"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 10748,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, AZ12489875-002 inhibited growth of lung small cell carcinoma cells in a dose-dependent manner in culture (PMID: 23844053).",
            "molecularProfile": {
                "id": 27742,
                "profileName": "EPHB4 positive"
            },
            "therapy": {
                "id": 3418,
                "therapyName": "AZ12489875-002",
                "synonyms": null
            },
            "indication": {
                "id": 5409,
                "name": "lung small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4341,
                    "pubMedId": 23844053,
                    "title": "The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic target.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23844053"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 10750,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, sEphB4-HSA treatment induced apoptosis, resulted in tumor growth inhibition in cell line xenograft models of Ephb4-positive lung small cell carcinoma (PMID: 23844053).",
            "molecularProfile": {
                "id": 27742,
                "profileName": "EPHB4 positive"
            },
            "therapy": {
                "id": 3013,
                "therapyName": "sEphB4-HSA",
                "synonyms": null
            },
            "indication": {
                "id": 5409,
                "name": "lung small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4341,
                    "pubMedId": 23844053,
                    "title": "The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic target.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23844053"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 27742,
            "profileName": "EPHB4 positive",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}